PL321538A1 - Additional protein of a human interleukin-1 receptor - Google Patents
Additional protein of a human interleukin-1 receptorInfo
- Publication number
- PL321538A1 PL321538A1 PL96321538A PL32153896A PL321538A1 PL 321538 A1 PL321538 A1 PL 321538A1 PL 96321538 A PL96321538 A PL 96321538A PL 32153896 A PL32153896 A PL 32153896A PL 321538 A1 PL321538 A1 PL 321538A1
- Authority
- PL
- Poland
- Prior art keywords
- receptor
- human interleukin
- additional protein
- protein
- additional
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37626895A | 1995-01-23 | 1995-01-23 | |
PCT/EP1996/000181 WO1996023067A1 (en) | 1995-01-23 | 1996-01-17 | Human interleukin-1 receptor accessory protein |
Publications (1)
Publication Number | Publication Date |
---|---|
PL321538A1 true PL321538A1 (en) | 1997-12-08 |
Family
ID=23484321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL96321538A PL321538A1 (en) | 1995-01-23 | 1996-01-17 | Additional protein of a human interleukin-1 receptor |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0808365A1 (en) |
JP (1) | JPH10512453A (en) |
AR (1) | AR003919A1 (en) |
AU (1) | AU4537096A (en) |
BR (1) | BR9606837A (en) |
CA (1) | CA2210724A1 (en) |
CO (1) | CO4480033A1 (en) |
CZ (1) | CZ208197A3 (en) |
EA (1) | EA199700265A1 (en) |
FI (1) | FI973089A0 (en) |
HU (1) | HUP9702458A2 (en) |
IL (1) | IL116796A0 (en) |
MX (1) | MX9705501A (en) |
NO (1) | NO973404L (en) |
PE (1) | PE64396A1 (en) |
PL (1) | PL321538A1 (en) |
TR (1) | TR199700652T1 (en) |
WO (1) | WO1996023067A1 (en) |
ZA (1) | ZA96333B (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7011696A (en) * | 1996-08-26 | 1998-03-19 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
US6974682B1 (en) | 1996-08-26 | 2005-12-13 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
ES2615357T3 (en) | 1996-12-06 | 2017-06-06 | Amgen Inc. | Combination therapy using an IL-1 inhibitor to treat IL-1 mediated diseases |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
EP0979282A1 (en) * | 1997-04-30 | 2000-02-16 | F. Hoffmann-La Roche Ag | Rat st38.2 chemokine |
US6280955B1 (en) * | 1997-12-16 | 2001-08-28 | Tularik Inc. | Interleukin-1 receptor accessory proteins, nucleic acids and methods |
AU755391B2 (en) | 1997-12-23 | 2002-12-12 | Immunex Corporation | SIGIRR DNA and polypeptides |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
WO2002064630A2 (en) * | 2000-10-31 | 2002-08-22 | Immunex Corporation | Il-1 receptor accessory protein |
GB2375604A (en) * | 2001-05-18 | 2002-11-20 | Warner Lambert Co | Methods for screening using interleukin soluble trimolecular complex |
PL222211B1 (en) | 2001-06-26 | 2016-07-29 | Amgen Fremont Inc | Antibodies to opgl |
KR100453877B1 (en) | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | METHOD OF MANUFACTURING Ig-FUSION PROTEINS BY CONCATAMERIZATION, TNFR/Fc FUSION PROTEINS MANUFACTURED BY THE METHOD, DNA CODING THE PROTEINS, VECTORS INCLUDING THE DNA, AND CELLS TRANSFORMED BY THE VECTOR |
AU2002324625B2 (en) * | 2001-08-07 | 2008-05-08 | Immunex Corporation | Interleukin-1 receptors in the treatment of diseases |
NZ593428A (en) | 2002-09-06 | 2013-01-25 | Amgen Inc | Therapeutic human anti-il-1r1 monoclonal antibody |
AU2005231822B2 (en) | 2004-04-02 | 2011-07-21 | Swedish Orphan Biovitrum Ab (Publ) | Methods of reducing aggregation of IL-1ra |
US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
WO2005105830A1 (en) * | 2004-05-05 | 2005-11-10 | Valorisation-Recherche, Societe En Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
US20090048161A1 (en) * | 2005-05-05 | 2009-02-19 | Valorisation Hsj, Societe En Commandite | Cytokine receptor modulators and uses thereof |
AR056806A1 (en) | 2005-11-14 | 2007-10-24 | Amgen Inc | RANKL- PTH / PTHRP ANTIBODY CHEMICAL MOLECULES |
JP2011515497A (en) | 2008-03-26 | 2011-05-19 | セレラント セラピューティクス インコーポレイテッド | Immunoglobulins and / or Toll-like receptor proteins associated with myeloid hematological proliferative diseases and uses thereof |
EP2196476A1 (en) | 2008-12-10 | 2010-06-16 | Novartis Ag | Antibody formulation |
GB2472856B (en) * | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
EP2665749B1 (en) * | 2011-01-19 | 2016-01-13 | Cantargia AB | Anti-il1rap antibodies and their use for treating solid tumours |
WO2012177595A1 (en) * | 2011-06-21 | 2012-12-27 | Oncofactor Corporation | Compositions and methods for the therapy and diagnosis of cancer |
WO2013006490A2 (en) | 2011-07-01 | 2013-01-10 | Cellerant Therapeutics, Inc. | Antibodies that specifically bind to tim3 |
GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
GB201413913D0 (en) | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
CN115505042A (en) | 2015-06-26 | 2022-12-23 | 赛诺菲生物技术公司 | Monoclonal anti-IL-1 RACP antibodies |
EP3241845A1 (en) | 2016-05-06 | 2017-11-08 | MAB Discovery GmbH | Humanized anti-il-1r3 antibodies |
US10041044B2 (en) | 2016-07-29 | 2018-08-07 | Trustees Of Boston University | Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development |
EP3401332A1 (en) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anti-il-1r3 antibodies for use in inflammatory conditions |
CA3067637A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free dna |
TW202021618A (en) | 2018-08-17 | 2020-06-16 | 美商23與我有限公司 | Anti-il1rap antibodies and methods of use thereof |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
WO2021236962A1 (en) | 2020-05-20 | 2021-11-25 | The Medical College Of Wisconsin, Inc. | Compositions and methods for inhibiting cytokine-release syndrome |
CN114835799A (en) * | 2021-05-28 | 2022-08-02 | 百奥赛图江苏基因生物技术有限公司 | Construction method and application of IL1RAP gene humanized non-human animal |
-
1996
- 1996-01-15 PE PE1996000031A patent/PE64396A1/en not_active Application Discontinuation
- 1996-01-16 ZA ZA96333A patent/ZA96333B/en unknown
- 1996-01-17 EA EA199700265A patent/EA199700265A1/en unknown
- 1996-01-17 PL PL96321538A patent/PL321538A1/en unknown
- 1996-01-17 HU HU9702458A patent/HUP9702458A2/en unknown
- 1996-01-17 MX MX9705501A patent/MX9705501A/en unknown
- 1996-01-17 CZ CZ972081A patent/CZ208197A3/en unknown
- 1996-01-17 WO PCT/EP1996/000181 patent/WO1996023067A1/en not_active Application Discontinuation
- 1996-01-17 CA CA002210724A patent/CA2210724A1/en not_active Abandoned
- 1996-01-17 AU AU45370/96A patent/AU4537096A/en not_active Abandoned
- 1996-01-17 TR TR97/00652T patent/TR199700652T1/en unknown
- 1996-01-17 JP JP8522598A patent/JPH10512453A/en active Pending
- 1996-01-17 IL IL11679696A patent/IL116796A0/en unknown
- 1996-01-17 BR BR9606837A patent/BR9606837A/en unknown
- 1996-01-17 EP EP96901291A patent/EP0808365A1/en not_active Withdrawn
- 1996-01-19 AR ARP960101095A patent/AR003919A1/en unknown
- 1996-01-22 CO CO96002329A patent/CO4480033A1/en unknown
-
1997
- 1997-07-22 FI FI973089A patent/FI973089A0/en unknown
- 1997-07-23 NO NO973404A patent/NO973404L/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA96333B (en) | 1996-07-23 |
JPH10512453A (en) | 1998-12-02 |
HUP9702458A2 (en) | 1998-04-28 |
PE64396A1 (en) | 1997-01-28 |
WO1996023067A1 (en) | 1996-08-01 |
CZ208197A3 (en) | 1997-11-12 |
CA2210724A1 (en) | 1996-08-01 |
NO973404D0 (en) | 1997-07-23 |
FI973089A (en) | 1997-07-22 |
AR003919A1 (en) | 1998-09-30 |
EA199700265A1 (en) | 1998-04-30 |
AU4537096A (en) | 1996-08-14 |
NO973404L (en) | 1997-07-23 |
CO4480033A1 (en) | 1997-07-09 |
IL116796A0 (en) | 1996-05-14 |
TR199700652T1 (en) | 1998-02-21 |
FI973089A0 (en) | 1997-07-22 |
MX9705501A (en) | 1997-10-31 |
BR9606837A (en) | 1998-05-26 |
EP0808365A1 (en) | 1997-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL321538A1 (en) | Additional protein of a human interleukin-1 receptor | |
EP0828751A4 (en) | Human neuropeptide receptor | |
AU2236895A (en) | Human g-protein coupled receptors | |
AU2766395A (en) | Human g-protein receptor hgber32 | |
IL116924A (en) | Preparation of n-aryl - and n-hetarylhydroxylamines | |
AU2662695A (en) | Human g-protein receptor hpraj70 | |
EP0815133A4 (en) | Human stat4 | |
AU6035398A (en) | Human c5a-like receptor | |
AU2663495A (en) | Human g-protein receptor hcegh45 | |
AU4459196A (en) | Sustained-release preparation and use | |
AU8019494A (en) | Human endothelin-bombesin receptor | |
EP0812329A4 (en) | Human g-protein coupled receptor | |
EP0833846A4 (en) | Human g-protein coupled receptor (hetgq23) | |
ZA968873B (en) | Isomerisation of equillin | |
NZ307236A (en) | Preparation of streptogramins | |
IL117786A (en) | Preparation of alpha-bisoximes | |
AU6779798A (en) | Novel human cytokine/steroid receptor protein | |
AU2699695A (en) | Human amine receptor | |
AU1270099A (en) | Human progesterone receptor complex p23-like protein | |
AU2699795A (en) | Human g-protein receptor hibef51 | |
AU4189196A (en) | Expression inhibitor against human interleukin-6 receptor | |
GB9511109D0 (en) | Receptor proteins | |
GB9403285D0 (en) | Human glutamate receptor protein | |
GB9415532D0 (en) | Human glutamate receptor protein | |
GB9508618D0 (en) | Therapeutic protein |